Stoke Therapeutics, Inc. (STOK) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Stoke Therapeutics third quarter 2025 business and financial update. At this time, all participants are in listen only mode. After the speaker's presentation, there will be a question and answer session to ask a question. During this session, you need to press star one one on your telephone. You would then hear an automated message advising your hand is raised to withdraw your question. Please press star one one again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Thomas Leggett, Chief Financial Officer. Please go ahead. Good afternoon and welcome to Stoke Therapeutics' third quarter 2025 conference call. I'm Thomas Leggett, Chief Financial Officer at Stoke Therapeutics. Joining me are Ian Smith, our Chief Executive Officer, and Dr. Barry Tico, Chief Medical Officer. Jason Hoyt, Chief Patient Officer, will join us for the Q&A portion. Today's webcast presentation is available in the Investor News section of our website. It is being recorded and will be available for replay later today. Before we begin, please note that today's discussion includes forward-looking statements. These are subject to risks and uncertainties, and actual results may differ materially. Please refer to our filings of the SEC for additional information. With that, I will turn the call over to Ian. Welcome, everyone, and thank you for joining us today. I'm honored to have been asked to serve as the CEO of Stoke Therapeutics. This is an incredible company with significant opportunity ahead of it. I could not be more excited to be part of the team as we advance Zoriva Nursing through phase three and build the company to deliver long-term value to patients,...